Completed

Phase 2
Age: 40Years +
All Genders
ID00000404

Effects of Comprehensive Care for Knee Osteoarthritis (OA)

Led by Indiana University · Updated on 2013-04-30

300

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

N

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

We will study 300 people with knee osteoarthritis (OA) who receive their medical care from a large health maintenance organization (HMO) in Indianapolis. Our study will evaluate a comprehensive plan for treatment of knee OA by primary care physicians. Primary care physicians will provide standard care for knee OA to half of the study participants (150 people), and will use the comprehensive treatment plan guidelines to treat the other half. The comprehensive plan includes careful use of medications along with non-drug approaches such as patient education, exercise, and social support. People who participate in the study will receive care for knee OA for 1 year. We will measure the results (outcomes) of treatment at the start of the study and at 3 months, 6 months, and 12 months after patients join the study. The results we will measure include joint pain, physical function, drug side effects, quality of life, satisfaction with OA care, and the cost of medical care.

CONDITIONS

Official Title

Effects of Comprehensive Care for Knee OA

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Study participants must be treated for chronic knee pain by a primary care physician at a participating HMO and satisfy American College of Rheumatology Clinical Criteria for the diagnosis of knee OA.
  • All subjects will be able to read and write English, have a telephone, and give informed consent.
Not Eligible

You will not qualify if you...

  • Significant hematologic, renal, hepatic, or cardiovascular disease (but not including mild/moderate hypertension) or any other serious medical condition that might preclude the subject's ability to participate fully in the project, keep clinic appointments, etc.
  • Conditions other than knee OA which limit lower extremity function and mobility and/or would confound the evaluation of knee pain and function (e.g., clinically significant spinal or hip arthritis, painful or dysfunctional feet, peripheral vascular disease, lumbar radiculopathy, stroke, etc.).
  • A known "secondary" cause of OA, including acute or chronic infectious arthritis; crystal-induced arthritis; systemic inflammatory connective tissue disease (e.g., rheumatoid arthritis, systemic lupus erythematosus); osteonecrosis; Paget's disease; or metabolic diseases, such as hemochromatosis, Wilson's disease, or ochronosis.

Trial Site Locations

Total: 1 location

1

Long Hospital, Room 545

Indianapolis, Indiana, United States, 46202-5103

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

0

Similar Trials

Effect of High-Intensity Pulsed Electromagnetic Field Therap...

Knee Osteoarthritis

Actively Recruiting

1 location

Study to Evaluate Safety, Tolerability, and How the Body Pro...

Post Herpetic Neuralgia

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee.

S A Mazzuca, K D Brandt, B P Katz...

https://pubmed.ncbi.nlm.nih.gov/9362595

Reduced utilization and cost of primary care clinic visits resulting from self-care education for patients with osteoarthritis of the knee.

S A Mazzuca, K D Brandt, B P Katz...

https://pubmed.ncbi.nlm.nih.gov/10366121